PE anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody

Pricing & Availability
Clone
RB6-8C5 (See other available formats)
Other Names
Gr-1
Isotype
Rat IgG2b, κ
Ave. Rating
7 reviews
Product Citations
publications
RB6-8C5_PE_040912
C57BL/6 mouse bone marrow cells were stained with Ly-6G/Ly-6C (clone RB6-8C5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram). Data shown was gated on myeloid cell population.
  • RB6-8C5_PE_040912
    C57BL/6 mouse bone marrow cells were stained with Ly-6G/Ly-6C (clone RB6-8C5) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram). Data shown was gated on myeloid cell population.
See PE spectral data
Cat # Size Price Quantity Avail. Save
108407 50 µg $45
Check Availability


Need larger quantities of this item?
Request Bulk Quote
108408 200 µg $150
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Gr-1 is a 21-25 kD protein also known as Ly-6G/Ly-6C. This myeloid differentiation antigen is a glycosylphosphatidylinositol (GPI)-linked protein expressed on granulocytes and macrophages. In bone marrow, the expression levels of Gr-1 directly correlate with granulocyte differentiation and maturation; Gr-1 is also transiently expressed on bone marrow cells in the monocyte lineage. Immature Myeloid Gr-1+ cells play a role in the development of antitumor immunity.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note: The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm filtered) is recommended for functional assays (Cat. No. 108414). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 108436) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
Product Citations
  1. Mosa A, et al. 2009. Infect Immun. 77:2908. PubMed
  2. Voronov E, et al. 2010. Int Immunol. 1.086805556. PubMed
  3. Stumpfova M, et al. 2010. Cancer Res . 70:2962. PubMed
  4. Casey S, et al. 2011. Mol Endocrinol. 25:933. PubMed
  5. Weimershaus M, et al. 2012. J Immunol. 188:1789. PubMed
  6. Rashid O, et al. 2013. Surgery. 153:771. PubMed
  7. Beyerle A, et al. 2011. J Control Release. 151:51. PubMed
  8. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  9. Liu X, et al. 2013. Diabetes. 62:4228. PubMed
  10. Pashover-Schallinger E, et al. 2012. FASEB J. 26:3891. PubMed
  11. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  12. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  13. Feng M, et al. 2014. Int Immunopharmacol. 19:267. PubMed
  14. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  15. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  16. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  17. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  18. Filina J, et al. 2014. Cell Signal. 26:2138. PubMed
  19. Crnej A, et al. 2015. Invest Ophthalmol Vis Sci . 56:185. PubMed
  20. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  21. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  22. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  23. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  24. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  25. Drobek A, et al. 2015. J Immunol. 195: 3416 - 3426. PubMed
  26. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  27. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  28. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  29. Ramos-Sevillano E, et al. 2016. PLoS One. 12: 1005500. PubMed
  30. Lira R, et al. 2016. PLoS One. 11: 0157475. PubMed
  31. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  32. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
  33. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  34. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  35. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  36. Lee Y, et al. 2017. PLoS One.. 10.1371/journal.pone.0183028. PubMed
  37. Hawila E, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.104. PubMed
  38. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  39. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  40. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  41. Curtis MW, et al. 2018. Infect Immun. 86:e00186. PubMed
  42. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  43. Chinta KC, et al. 2018. Cell Rep. 25:1938. PubMed
  44. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  45. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  46. Grzelak A, et al. 2018. Int J Mol Sci. 19:. PubMed
  47. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
Publication Library
RRID
AB_313372 (BioLegend Cat. No. 108407)
AB_313373 (BioLegend Cat. No. 108408)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G/Ly-6C on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 12/09/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account